Windtree Therapeutics Inc (WINT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Windtree Therapeutics Inc (WINT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9885
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead development product Aerosurf (lucinactant for inhalation), is an investigational combination drug/device product for the treatment of respiratory distress syndrome (RDS) in premature infants. Its technology platforms comprise a novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant, which is structurally similar to pulmonary surfactant, and proprietary drug delivery technologies for the delivery of aerosolized KL4 surfactant and other inhaled therapies. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.

Windtree Therapeutics Inc (WINT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Windtree Therapeutics Enters into Agreement with Eleison Pharma 11
Discovery Labs Enters into Co-Development Agreement with Battelle Memorial Institute 12
Discovery Labs Amends Agreement with Battelle Memorial Institute 13
Licensing Agreements 15
Lee’s Pharma Enters into Licensing Agreement with Windtree Therapeutics 15
Equity Offering 17
Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 17
Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 19
Discovery Labs Raises USD40.2 Million in Public Offering of Units 21
Discovery Laboratories Completes Public Offering Of Shares For US$50 Million 23
Discovery Labs Completes Public Offering Of Shares For US$14.2 Million 24
Discovery Labs Announces Public Offering Of Shares For US$25 Million 25
Discovery Labs Completes Public Offering Of Common Stock For US$45 Million 26
Windtree Therapeutics Inc – Key Competitors 28
Windtree Therapeutics Inc – Key Employees 29
Windtree Therapeutics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Nov 14, 2017: Windtree Therapeutics Reports Third Quarter 2017 Financial Results 31
Aug 21, 2017: Windtree Therapeutics Reports Second Quarter 2017 Financial Results 33
May 15, 2017: Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates 35
Mar 31, 2017: Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates 37
Clinical Trials 39
Jan 04, 2018: Windtree Therapeutics to Provide AEROSURF and Business Updates 39
Jun 29, 2017: Windtree Announces Top-Line Results from AEROSURF Phase 2b Clinical Trial for the Treatment of Respiratory Distress Syndrome in Premature Infants 40
Apr 11, 2017: Windtree Announces Successful Completion of Second and Final AEROSURF Phase 2b Clinical Trial Interim Safety Review 42
Feb 16, 2017: Windtree Therapeutics’ Aerosolized KL4 Surfactant Reduces Lung Inflammation and Improves Survival in a High-Pathogen Avian Influenza Preclinical Study 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Windtree Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Windtree Therapeutics Enters into Agreement with Eleison Pharma 11
Discovery Labs Enters into Co-Development Agreement with Battelle Memorial Institute 12
Discovery Labs Amends Agreement with Battelle Memorial Institute 13
Lee’s Pharma Enters into Licensing Agreement with Windtree Therapeutics 15
Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 17
Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 19
Discovery Labs Raises USD40.2 Million in Public Offering of Units 21
Discovery Laboratories Completes Public Offering Of Shares For US$50 Million 23
Discovery Labs Completes Public Offering Of Shares For US$14.2 Million 24
Discovery Labs Announces Public Offering Of Shares For US$25 Million 25
Discovery Labs Completes Public Offering Of Common Stock For US$45 Million 26
Windtree Therapeutics Inc, Key Competitors 28
Windtree Therapeutics Inc, Key Employees 29
Windtree Therapeutics Inc, Other Locations 30
Windtree Therapeutics Inc, Subsidiaries 30

List of Figures
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Windtree Therapeutics Inc (WINT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Les Laboratoires Servier SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Les Laboratoires Servier SAS (Servier) researches, develops, manufactures and markets drugs for treating various diseases. The company's portfolio of marketed products treat central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, women's …
  • BioAtla LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary BioAtla LLC (BioAtla) is a biotechnology company that develops novel monoclonal antibodies and other cell based therapeutics. The company utilizes proprietary conditionally active biologics and comprehensive integrated antibody optimization platforms to develop novel therapies. It develops d …
  • Central Reinsurance Corporation:企業の戦略・SWOT・財務情報
    Central Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report Summary Central Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • American Air Filter Co Inc:企業の戦略的SWOT分析
    American Air Filter Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ra Pharmaceuticals Inc (RARX):医療機器:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • United Therapeutics Corp (UTHR)-医療機器分野:企業M&A・提携分析
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • Austevoll Seafood ASA:企業の戦略・SWOT・財務情報
    Austevoll Seafood ASA - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Toyo Engineering Corp:企業の戦略・SWOT・財務分析
    Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report Summary Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Abbott India Ltd (ABBOTINDIA):製薬・医療:M&Aディール及び事業提携情報
    Summary Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories discovers, develops, manufactures and markets branded generic pharmaceuticals, diagnostics tools, medical devices and nutritionals. Its product portfolio encompasses multi-specialty drugs, vitamins and a comprehensive range …
  • PGE Polska Grupa Energetyczna SA (PGE)-エネルギー分野:企業M&A・提携分析
    Summary PGE Polska Grupa Energetyczna S.A. (PGE) is a state owned energy utility, which produces and supplies electricity in Poland. It carries out lignite mining activities, electricity generation from fossil fuels (lignite, hard coal and natural gas) and renewable energy sources (hydro, wind and b …
  • Obton AS-エネルギー分野:企業M&A・提携分析
    Summary Obton A/S (Obton) is an investment company that specializes in management of assets within renewable energy. The company's investment process include screening process which inludes verification of prerequisites such as financial terms, amount of irradiation, power purchase agreement and fee …
  • Walker Greenbank PLC:企業の戦略・SWOT・財務情報
    Walker Greenbank PLC - Strategy, SWOT and Corporate Finance Report Summary Walker Greenbank PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Daiwa House Industry Co Ltd (1925)-エネルギー分野:企業M&A・提携分析
    Summary Daiwa House Industry Co., Ltd. (Daiwa House) is a construction service provider. The company provides diversified real estate solutions such as planning, construction, leasing, management and operation of rental, pre-existing, and new buildings; renovation and real estate agency services. It …
  • WEC Energy Group Inc (WEC):電力:M&Aディール及び事業提携情報
    Summary WEC Energy Group, Inc. (WEC) is a diversified holding company that carries out the generation and distribution of electricity in southeastern Wisconsin, east central Wisconsin, northern Wisconsin, and Michigan's Upper Peninsula; and transports and distributes natural gas in the upper peninsu …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務情報
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Thermo Fisher Scientific Inc (TMO):医療機器:M&Aディール及び事業提携情報
    Summary Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories. It offers solutions for cellular analysis and biology, …
  • Sykes Enterprises Inc (SYKE)
    Sykes Enterprises Inc (SYKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • AU Optronics Corp.:企業の戦略・SWOT・財務情報
    AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report Summary AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • Global Partners LP (GLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Global Partners LP (Global Partners) is a midstream logistics and marketing master limited partnership. It carries out purchasing, selling and logistics of transporting domestic and Canadian crude oil and other products by rail across its virtual pipeline from the mid-continent region of the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆